Literature DB >> 9012696

Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year period.

D G Savage1, R M Szydlo, J M Goldman.   

Abstract

To determine major presenting features of chronic myeloid leukaemia (CML) in current practice, we have reviewed the records of 430 patients with CML referred to the Hammersmith Hospital for allogeneic bone marrow transplantation since 1981. Approximately 20% of cases were diagnosed incidentally. Symptoms such as fatigue and weight loss were associated with greater degrees of leucocytosis and splenomegaly and lower haemoglobin levels. Most bleeding patients had normal or elevated platelet counts, suggesting that platelet dysfunction was the primary cause of haemorrhage. Although thrombocytosis was common, thrombosis was not seen. Male patients and the relatively young presented with higher WBC counts and larger spleens. The reason that these groups were diagnosed with more advanced leukaemia is not clear. Although retrospective and limited to a select group of relatively young patients, this is the largest series to be reported on CML at diagnosis, and the first such report in modern clinical practice.

Entities:  

Mesh:

Year:  1997        PMID: 9012696     DOI: 10.1046/j.1365-2141.1997.d01-1982.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  41 in total

Review 1.  [What should be done in weight loss of unknown origin?].

Authors:  A Schwenk
Journal:  Med Klin (Munich)       Date:  1998-12-15

2.  Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias.

Authors:  L A Tobin; C Robert; A P Rapoport; I Gojo; M R Baer; A E Tomkinson; F V Rassool
Journal:  Oncogene       Date:  2012-05-28       Impact factor: 9.867

3.  Measuring the symptom burden associated with the treatment of chronic myeloid leukemia.

Authors:  Loretta A Williams; Araceli G Garcia Gonzalez; Patricia Ault; Tito R Mendoza; Mary L Sailors; Janet L Williams; Furong Huang; Aziz Nazha; Hagop M Kantarjian; Charles S Cleeland; Jorge E Cortes
Journal:  Blood       Date:  2013-06-18       Impact factor: 22.113

4.  Bone infarcts in a case of chronic myeloid leukemia: chronic phase.

Authors:  Sanjeev Kumar Sharma; Tulika Seth; Pravas Mishra; Manoranjan Mahapatra
Journal:  Indian J Hematol Blood Transfus       Date:  2011-10-20       Impact factor: 0.900

5.  Symptoms of adult chronic and acute leukaemia before diagnosis: large primary care case-control studies using electronic records.

Authors:  Elizabeth A Shephard; Richard D Neal; Peter W Rose; Fiona M Walter; Willie Hamilton
Journal:  Br J Gen Pract       Date:  2016-03       Impact factor: 5.386

6.  Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells.

Authors:  Clara Guerzoni; Michela Bardini; Samanta A Mariani; Giovanna Ferrari-Amorotti; Paolo Neviani; Maria Luisa Panno; Ying Zhang; Robert Martinez; Danilo Perrotti; Bruno Calabretta
Journal:  Blood       Date:  2006-01-17       Impact factor: 22.113

7.  Pediatric chronic myeloid leukemia is a unique disease that requires a different approach.

Authors:  Nobuko Hijiya; Kirk R Schultz; Markus Metzler; Frederic Millot; Meinolf Suttorp
Journal:  Blood       Date:  2015-10-28       Impact factor: 22.113

8.  How I treat childhood CML.

Authors:  Jeffrey R Andolina; Steven M Neudorf; Seth J Corey
Journal:  Blood       Date:  2011-12-30       Impact factor: 22.113

9.  Spontaneous Acute Subdural Hematoma as an Initial Presentation of Chronic Myeloid Leukemia.

Authors:  Ankur Jain; Pooja Prasad; Sumita Chaudhry; D K Gupta; Sumita Saluja
Journal:  Indian J Hematol Blood Transfus       Date:  2019-03-22       Impact factor: 0.900

10.  FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.

Authors:  Paolo Neviani; Ramasamy Santhanam; Joshua J Oaks; Anna M Eiring; Mario Notari; Bradley W Blaser; Shujun Liu; Rossana Trotta; Natarajan Muthusamy; Carlo Gambacorti-Passerini; Brian J Druker; Jorge Cortes; Guido Marcucci; Ching-Shih Chen; Nicole M Verrills; Denis C Roy; Michael A Caligiuri; Clara D Bloomfield; John C Byrd; Danilo Perrotti
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.